Medication Prescribing

At the American Association of Clinical Endocrinology 2025 Annual Meeting, Jaime Almandoz, MD, MBA, FTOS, discussed the importance of continuing medical treatment for patients with obesity following...

At the American Association of Clinical Endocrinology 2025 Annual Meeting, Daniel Drucker, OC, MD, FRCPC, FRSC, FRS, discussed the evolving scope of GLP-1–based therapies, highlighting emerging molecules,...

In a cross-sectional survey presented at the American Academy of Pain Medicine PainConnect 2025 annual meeting in Austin, TX, researchers found that nearly 2 in 5 patients reported inadequate pain relief...

A study identified biomarkers associated with response and resistance to nivolumab plus cabozantinib in recurrent endometrial cancer, offering insights for future therapies.

A recent presentation at the American College of Physicians Internal Medicine Meeting 2025 highlighted updated approaches to inpatient diabetes management.

In a phase 2b trial, a novel analgesic outperformed placebo and reduced opioid use in patients undergoing bunionectomy. Researchers presented their study results at the American Academy of Pain Medicine...

A study presented at the American College of Cardiology's 74th Annual Scientific Session found that GLP-1RA use in patients with psoriasis was linked to a lower incidence of major adverse cardiovascular...

A real-world retrospective study found that adding GLP-1 receptor agonists to hormone therapy may reduce endometrial cancer risk in women with benign uterine or endometrial hyperplasia. This study was...

Researchers evaluated the safety and efficacy of dolutegravir plus lamivudine in treatment-naive individuals with HIV without baseline resistance testing.

A study assesses whether the dual sodium–glucose co-transporter (SGLT) 1/2 inhibitor sotagliflozin reduces ischemic events in diabetes and kidney disease.